BioMarin Announces Third Quarter 2020 Total Revenues of $477 Million
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/3/2026
- S&P 500, Nasdaq edge higher ahead of midterm results; Apple falls
- Apple shares slip amid guidance for tightening margins, slowing services growth
- Rising shorts cool U.S. large-cap positioning, cutting liquidation risk: Citi
- Apple's 'unprecedented' memory warning adds fuel to wobbly Micron, SK hynix trade
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
| BioMarin Pharmaceuticals, Inc. (NASDAQ: BMRN) | Delayed: 55.05 -2.39 (4.16%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $57.44 | 52 Week High | $108.96 | |||
| Open | $53.06 | 52 Week Low | $62.12 | |||
| Day High | $55.80 | P/E | N/A | |||
| Day Low | $52.50 | EPS | $-1.27 | |||
| Volume | 1,529,366 | |||||
